Thomas B. Julian

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

T. Julian, J. Costantino, N. Wolmark, 2007, The Lancet. Oncology.

Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial: A Randomized Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer

T. Julian, D. Weaver, D. Krag, 2005, Annals of surgery.

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer.

T. Julian, N. Wolmark, K. Jasnosz, 2001, American journal of surgery.

Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial.

W. Curran, T. Julian, F. Vicini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.